Registration open & call for abstracts 

The 15th Netherlands Conference on HIV Pathogenesis, Epidemiology, Prevention and Treatment (NCHIV) is set to once again take place on-site at the Royal Tropical Institute (KIT) in Amsterdam on Tuesday 22 November 2022. It will in principle be an on-site conference, with an option to take part online.

We are pleased to announce our plenary sessions:

–  Antibody-based treatments for HIV
Dr. Marina Caskey, Associate Professor of Clinical Investigation at The Rockefeller University, New York, United States

–  Immune and hormonal mechanisms of cardiometabolic risk in women living with HIV
Markella Zanni, Associate Professor of Medicine at Harvard Medical School; Director of Women’s Health Research in the Metabolism Unit at Massachusetts General Hospital, Boston, United States

–  Scalable mental health interventions for HIV: lessons from research in the Global North and South
Pamela Collins, Professor of Psychiatry & Behavioral Sciences and Global Health, University of Washington; Executive Director at International Training and Education Center for Health (I-TECH), Seattle, United States

The full conference programme incl. all selected oral abstracts will be announced as soon as possible.

Registration

NCHIV22 conference fees (same for on-site or online):

  • Standard registration: € 185
  • Postgraduate students/A(N)IOS/nurse/nurse practitioner: € 125
  • Undergraduate students: € 50
  • Credentialed members of the media may attend for free. Please send an email to organisation@nchiv.org

Please note that registration for NCHIV22 is a two-step process. An account for the MedTalks platform is required. Detailed instructions are available on the registration page: www.medtalks.nl/nchiv2022

If you have any issues during the registration process please contact events@medtalks.nl or organisation@nchiv.org.     

Register

Abstract submission

Abstract submissions may include results from original research across all scientific disciplines, relevant to the themes of the conference (HIV pathogenesis, epidemiology, prevention and treatment), and conducted primarily by researchers from Dutch institutions working either in or outside the Netherlands. Abstracts on other viral infections, including viral hepatitis, SARS-CoV-2 and monkeypox in the context of or of direct relevance to the field of HIV are also very much welcomed.

Abstract submission deadline: Friday 23 September 2022 18:00 CET

submit abstract

NCHIV

NCHIV serves as platform for stakeholders in the Netherlands to share and discuss the latest insights and developments in research concerning the pathogenesis, epidemiology, prevention and treatment of HIV. The annual program hosted in English, includes invited lectures, presentations of original research by a national and international faculty, as well as sessions which link research to societal impact and policy development.

NCHIV is organised by